InsiderClue
Stocks · Health care · Pharmaceutical Preparations

NEKTAR THERAPEUTICS

NKTR Clue Score14
United States Fiscal year ends December CIK 0000906709 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Howard W Robin
18 Aug 2026
President & CEO
Sell
418
$71.98
$30.09K
Jonathan Zalevsky
18 Aug 2026
Chief R&D Officer
Sell
186
$71.98
$13.39K
Howard W Robin
19 May 2026
President & CEO
Sell
444
$65.51
$29.09K
Jonathan Zalevsky
19 May 2026
Chief R&D Officer
Sell
199
$65.51
$13.04K
Howard W Robin
18 Feb 2026
President & CEO
Sell
423
$73.00
$30.88K
Jonathan Zalevsky
18 Feb 2026
Chief R&D Officer
Sell
180
$73.00
$13.14K
Howard W Robin
25 Nov 2025
President & CEO
Sell
2,207
$54.28
$119.80K
Mark Andrew Wilson
25 Nov 2025
Chief Legal Officer
Sell
630
$54.28
$34.20K
Jonathan Zalevsky
25 Nov 2025
Chief R&D Officer
Sell
1,157
$54.28
$62.80K
Show all 16 transactions →

What was left out

Form 4 filings counted 22
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 49,596
History held since 7 Nov 2006